# Encapsulated Faecal Microbiota Transplantation to Preserve Residual Beta Cell Function in Type 1 Diabetes Mellitus

> **NCT05323162** · NA · UNKNOWN · sponsor: **Nordin Hanssen** · enrollment: 10 (estimated)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **OTHER:** encapsulated autologous fecal microbiota transplantation

## Key facts

- **NCT ID:** NCT05323162
- **Lead sponsor:** Nordin Hanssen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04
- **Primary completion:** 2023-04
- **Final completion:** 2023-10
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2022-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05323162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05323162, "Encapsulated Faecal Microbiota Transplantation to Preserve Residual Beta Cell Function in Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05323162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*